Edition:
India

Soligenix Inc (SNGX.OQ)

SNGX.OQ on NASDAQ Stock Exchange Capital Market

1.22USD
1:30am IST
Change (% chg)

$0.07 (+6.09%)
Prev Close
$1.15
Open
$1.16
Day's High
$1.26
Day's Low
$1.16
Volume
37,016
Avg. Vol
33,071
52-wk High
$3.70
52-wk Low
$0.91

Chart for

About

Soligenix, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical... (more)

Overall

Beta: 2.19
Market Cap(Mil.): $13.11
Shares Outstanding(Mil.): 5.72
Dividend: --
Yield (%): --

Financials

BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning

* SOLIGENIX RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR RIVAX® FOR PREVENTION OF RICIN POISONING Source text for Eikon: Further company coverage:

22 Mar 2018

BRIEF-Soligenix - Driving Towards Key Inflection Points With Two Pivotal Phase 3 Clinical Trials

* SOLIGENIX - DRIVING TOWARDS KEY INFLECTION POINTS WITH TWO PIVOTAL PHASE 3 CLINICAL TRIALS Source text for Eikon: Further company coverage:

25 Jan 2018

Earnings vs. Estimates